Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer

(Abstracted from N Engl J Med 2022;386:437–448)
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: GYNECOLOGY: GYNECOLOGIC ONCOLOGY Source Type: research